Antibodies against low-Density lipoprotein receptor-Related protein 4 induce myasthenia gravis

Chengyong Shen, Yisheng Lu, Bin Zhang, Dwight Figueiredo, Jonathan Bean, Jiung Jung, Haitao Wu, Arnab Barik, Dong Min Yin, Wen Cheng Xiong, Lin Mei

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Myasthenia gravis (MG) is the most common disorder affecting the neuromuscular junction (NMJ). MG is frequently caused by autoantibodies against acetylcholine receptor (AChR) and a kinase critical for NMJ formation, MuSK; however, a proportion of MG patients are double-negative for anti-AChR and anti-MuSK antibodies. Recent studies in these subjects have identified autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), an agrin receptor also critical for NMJ formation. LRP4 autoantibodies have not previously been implicated in MG pathogenesis. Here we demonstrate that mice immunized with the extracellular domain of LRP4 generated anti-LRP4 antibodies and exhibited MG-associated symptoms, including muscle weakness, reduced compound muscle action potentials (CMAPs), and compromised neuromuscular transmission. Additionally, fragmented and distorted NMJs were evident at both the light microscopic and electron microscopic levels. We found that anti-LRP4 sera decreased cell surface LRP4 levels, inhibited agrin-induced MuSK activation and AChR clustering, and activated complements, revealing potential pathophysiological mechanisms. To further confirm the pathogenicity of LRP4 antibodies, we transferred IgGs purified from LRP4-immunized rabbits into naive mice and found that they exhibited MG-like symptoms, including reduced CMAP and impaired neuromuscular transmission. Together, these data demonstrate that LRP4 autoantibodies induce MG and that LRP4 contributes to NMJ maintenance in adulthood.

Original languageEnglish (US)
Pages (from-to)5190-5202
Number of pages13
JournalJournal of Clinical Investigation
Volume123
Issue number12
DOIs
StatePublished - Dec 2 2013

Fingerprint

LDL-Receptor Related Proteins
Lipoprotein Receptors
LDL Receptors
Myasthenia Gravis
Antibodies
Autoantibodies
Neuromuscular Junction
Proteins
Cholinergic Receptors
Action Potentials
Neuromuscular Junction Diseases
Agrin
Muscles
Muscle Weakness
Cell Surface Receptors
Cluster Analysis
Virulence
Blood Proteins
Anti-Idiotypic Antibodies
Maintenance

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Shen, C., Lu, Y., Zhang, B., Figueiredo, D., Bean, J., Jung, J., ... Mei, L. (2013). Antibodies against low-Density lipoprotein receptor-Related protein 4 induce myasthenia gravis. Journal of Clinical Investigation, 123(12), 5190-5202. https://doi.org/10.1172/JCI66039

Antibodies against low-Density lipoprotein receptor-Related protein 4 induce myasthenia gravis. / Shen, Chengyong; Lu, Yisheng; Zhang, Bin; Figueiredo, Dwight; Bean, Jonathan; Jung, Jiung; Wu, Haitao; Barik, Arnab; Yin, Dong Min; Xiong, Wen Cheng; Mei, Lin.

In: Journal of Clinical Investigation, Vol. 123, No. 12, 02.12.2013, p. 5190-5202.

Research output: Contribution to journalArticle

Shen, C, Lu, Y, Zhang, B, Figueiredo, D, Bean, J, Jung, J, Wu, H, Barik, A, Yin, DM, Xiong, WC & Mei, L 2013, 'Antibodies against low-Density lipoprotein receptor-Related protein 4 induce myasthenia gravis', Journal of Clinical Investigation, vol. 123, no. 12, pp. 5190-5202. https://doi.org/10.1172/JCI66039
Shen, Chengyong ; Lu, Yisheng ; Zhang, Bin ; Figueiredo, Dwight ; Bean, Jonathan ; Jung, Jiung ; Wu, Haitao ; Barik, Arnab ; Yin, Dong Min ; Xiong, Wen Cheng ; Mei, Lin. / Antibodies against low-Density lipoprotein receptor-Related protein 4 induce myasthenia gravis. In: Journal of Clinical Investigation. 2013 ; Vol. 123, No. 12. pp. 5190-5202.
@article{2fec874b12cb4af8be05776cbe86e815,
title = "Antibodies against low-Density lipoprotein receptor-Related protein 4 induce myasthenia gravis",
abstract = "Myasthenia gravis (MG) is the most common disorder affecting the neuromuscular junction (NMJ). MG is frequently caused by autoantibodies against acetylcholine receptor (AChR) and a kinase critical for NMJ formation, MuSK; however, a proportion of MG patients are double-negative for anti-AChR and anti-MuSK antibodies. Recent studies in these subjects have identified autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), an agrin receptor also critical for NMJ formation. LRP4 autoantibodies have not previously been implicated in MG pathogenesis. Here we demonstrate that mice immunized with the extracellular domain of LRP4 generated anti-LRP4 antibodies and exhibited MG-associated symptoms, including muscle weakness, reduced compound muscle action potentials (CMAPs), and compromised neuromuscular transmission. Additionally, fragmented and distorted NMJs were evident at both the light microscopic and electron microscopic levels. We found that anti-LRP4 sera decreased cell surface LRP4 levels, inhibited agrin-induced MuSK activation and AChR clustering, and activated complements, revealing potential pathophysiological mechanisms. To further confirm the pathogenicity of LRP4 antibodies, we transferred IgGs purified from LRP4-immunized rabbits into naive mice and found that they exhibited MG-like symptoms, including reduced CMAP and impaired neuromuscular transmission. Together, these data demonstrate that LRP4 autoantibodies induce MG and that LRP4 contributes to NMJ maintenance in adulthood.",
author = "Chengyong Shen and Yisheng Lu and Bin Zhang and Dwight Figueiredo and Jonathan Bean and Jiung Jung and Haitao Wu and Arnab Barik and Yin, {Dong Min} and Xiong, {Wen Cheng} and Lin Mei",
year = "2013",
month = "12",
day = "2",
doi = "10.1172/JCI66039",
language = "English (US)",
volume = "123",
pages = "5190--5202",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "12",

}

TY - JOUR

T1 - Antibodies against low-Density lipoprotein receptor-Related protein 4 induce myasthenia gravis

AU - Shen, Chengyong

AU - Lu, Yisheng

AU - Zhang, Bin

AU - Figueiredo, Dwight

AU - Bean, Jonathan

AU - Jung, Jiung

AU - Wu, Haitao

AU - Barik, Arnab

AU - Yin, Dong Min

AU - Xiong, Wen Cheng

AU - Mei, Lin

PY - 2013/12/2

Y1 - 2013/12/2

N2 - Myasthenia gravis (MG) is the most common disorder affecting the neuromuscular junction (NMJ). MG is frequently caused by autoantibodies against acetylcholine receptor (AChR) and a kinase critical for NMJ formation, MuSK; however, a proportion of MG patients are double-negative for anti-AChR and anti-MuSK antibodies. Recent studies in these subjects have identified autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), an agrin receptor also critical for NMJ formation. LRP4 autoantibodies have not previously been implicated in MG pathogenesis. Here we demonstrate that mice immunized with the extracellular domain of LRP4 generated anti-LRP4 antibodies and exhibited MG-associated symptoms, including muscle weakness, reduced compound muscle action potentials (CMAPs), and compromised neuromuscular transmission. Additionally, fragmented and distorted NMJs were evident at both the light microscopic and electron microscopic levels. We found that anti-LRP4 sera decreased cell surface LRP4 levels, inhibited agrin-induced MuSK activation and AChR clustering, and activated complements, revealing potential pathophysiological mechanisms. To further confirm the pathogenicity of LRP4 antibodies, we transferred IgGs purified from LRP4-immunized rabbits into naive mice and found that they exhibited MG-like symptoms, including reduced CMAP and impaired neuromuscular transmission. Together, these data demonstrate that LRP4 autoantibodies induce MG and that LRP4 contributes to NMJ maintenance in adulthood.

AB - Myasthenia gravis (MG) is the most common disorder affecting the neuromuscular junction (NMJ). MG is frequently caused by autoantibodies against acetylcholine receptor (AChR) and a kinase critical for NMJ formation, MuSK; however, a proportion of MG patients are double-negative for anti-AChR and anti-MuSK antibodies. Recent studies in these subjects have identified autoantibodies against low-density lipoprotein receptor-related protein 4 (LRP4), an agrin receptor also critical for NMJ formation. LRP4 autoantibodies have not previously been implicated in MG pathogenesis. Here we demonstrate that mice immunized with the extracellular domain of LRP4 generated anti-LRP4 antibodies and exhibited MG-associated symptoms, including muscle weakness, reduced compound muscle action potentials (CMAPs), and compromised neuromuscular transmission. Additionally, fragmented and distorted NMJs were evident at both the light microscopic and electron microscopic levels. We found that anti-LRP4 sera decreased cell surface LRP4 levels, inhibited agrin-induced MuSK activation and AChR clustering, and activated complements, revealing potential pathophysiological mechanisms. To further confirm the pathogenicity of LRP4 antibodies, we transferred IgGs purified from LRP4-immunized rabbits into naive mice and found that they exhibited MG-like symptoms, including reduced CMAP and impaired neuromuscular transmission. Together, these data demonstrate that LRP4 autoantibodies induce MG and that LRP4 contributes to NMJ maintenance in adulthood.

UR - http://www.scopus.com/inward/record.url?scp=84890113189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890113189&partnerID=8YFLogxK

U2 - 10.1172/JCI66039

DO - 10.1172/JCI66039

M3 - Article

C2 - 24200689

AN - SCOPUS:84890113189

VL - 123

SP - 5190

EP - 5202

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 12

ER -